Hester Biosciences Limited (NSE:HESTERBIO)
India · Delayed Price · Currency is INR 2,431.50
-18.50 (-0.76%)
Jul 22, 2026, 3:30 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 20.67 billion as of July 22, 2026. Its market cap has increased by 28.72% in one year.
Market Cap
20.67B
Enterprise Value
22.62B
Revenue
3.34B
Ranking
n/a
PE Ratio
37.14
Stock Price
2,431.50
ChartMarket Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 20.67B, an increase of 93,641.46%. That is a compound annual growth rate of 25.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 20.67B | 52.60% |
| Dec 31, 2025 | 13.54B | -33.49% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 56.08B |
| Orchid Pharma | 51.89B |
| RPG Life Sciences | 49.58B |
| Solara Active Pharma Sciences | 26.92B |
| Beta Drugs | 25.02B |
| Indoco Remedies | 22.69B |
| Ind-Swift Laboratories | 20.60B |
| Sakar Healthcare | 19.55B |